After participating in CPHI Milan in 2024 and most recently in CPHI Shanghai in June 2025, we’re now preparing for Frankfurt and looking forward to reconnecting with familiar faces and making new connections!

As an independent German pharmaceutical consulting company, PharmaKorell has been supporting over 200 pharmaceutical and biotech companies in more than 30 countries since 2007. 

With a team of 26 experts, we offer services in the areas of Quality Management, QP Certification, Provision of Key Pharmaceutical Personnel, Import/Export, Business Development, Pharma Logistics & Packaging.

Take the opportunity to connect in person with three of our senior experts:
Dr Benedikt Ball
Dr Ulrich Korell
Dr Frank Wienen

We look forward to meeting you in person to explore growth opportunities and discuss how we can best support your business. Feel free to reach out to us via the event app or send us an email.

PharmaKorell has been awarded the kununu Top Company badge for the second year in a row.

Only about 5% of companies qualify for this badge each year, which makes this recognition all the more meaningful to us. Our average rating of 4.5 significantly exceeds the industry average in the medical/pharmaceutical sector (3.5) and consulting (3.9). Our employees particularly value career and development opportunities, our working environment, company culture, as well as topics such as equal opportunities and appreciation towards senior team members.

Our employees frequently highlight the following benefits: Company car, flexible working hours, home office, company phone, parking, accessibility, and regular team events. We are especially pleased that 90% are satisfied with their salary.

We continue to grow and are looking for new talent! We are always interested in qualified new colleagues for our sites in Lörrach and Munich. Feel free to reach out to us for an informal chat if you would like to learn more about your opportunities at PharmaKorell.

This year, our team outing took us to the Swiss Museum of Transport in Lucerne, the most visited museum in Switzerland and an inspiring place for anyone with an interest in mobility, technology and communication. After travelling together from Lörrach and Munich, we began the day with an engaging guided tour, which provided an overview of the museum’s impressive collection of locomotives, cars, aircraft and ship models, while also offering insights into Switzerland’s history of innovation.

After our lunch together, the afternoon allowed space for individual exploration: some of us explored the planetarium with its interactive journey through the solar system, while others were fascinated by the “Space Transformer”, which creates the sensation of weightlessness. The Swiss Chocolate Adventure, which brings the world of cocoa and chocolate production to life, was also a highlight for many.

However, the most valuable aspect was the shared experience and the personal exchange within the team, which, away from our usual working environment, opened up new perspectives and ideas.

We are pleased to welcome Dr Jens Lipka to PharmaKorell as Senior Consultant at our Munich office.

Jens brings with him extensive experience in the pharmaceutical industry, particularly in quality assurance and manufacturing. After several years working as a pharmacist in Munich, he took on his first leadership role in manufacturing at Fresenius Kabi.

He then joined STADAPHARM GmbH, where he served as Deputy Head of QA & QC and later as Head of Quality Systems & Compliance and Qualified Person. Before joining PharmaKorell, he was Head of Quality Systems at Takeda in Germany. 

Jens also has a strong academic background. He is a licensed pharmacist and holds a PhD in pharmaceutical technology from Philipps-University Marburg. To get to know him a little better, we asked Jens a few questions in a short interview:

What are the top three highlights of your career so far?

The key milestones in my career include earning my PhD in Natural Sciences, being appointed as a Qualified Person under the German Medicines Act (AMG) along with taking on a leadership role in quality assurance, and my current position as Senior Consultant at PharmaKorell.

What’s the best advice or life lesson you’ve ever received, and how does it influence your work? 

“It’s always worth looking beyond your own horizon” – both professionally and personally, this has proven to be great advice. Understanding more than just your own area allows you to better grasp the bigger picture and make more informed decisions. In team settings, this perspective also helps in understanding the needs and approaches of others, leading to more constructive and effective collaboration.

How were your first weeks at PharmaKorell, and what are you most looking forward to in your new role?

My first weeks at PharmaKorell have been very positive. I received a warm welcome and everything was well prepared for my arrival. The team is very collegial, and I’ve already started contributing to some projects. I’m particularly looking forward to applying my knowledge and expertise to upcoming assignments and seeing them through to successful completion.

CPHI China 2025 was once again a great success!

We had many constructive discussions with our valued existing and prospective clients and were happy to celebrate our partner companies BrightGene and Lunan on receiving their Internationalization Awards.

Chinese companies looking to expand into the European pharmaceutical market will find a reliable point of contact in PharmaKorell. We are currently supporting ten Chinese clients with company formation, regulatory compliance, QP Declaration , EU import and batch certification .

With our experienced team, including a specialist for intercultural communication and translations, we are well positioned to support business between China and Europe.

A heartfelt thank you to all the partners and contacts we had the pleasure of meeting at CPHI China. We look forward to staying in touch via LinkedIn and WeChat and of course to seeing some familiar faces again at CPHI Europe!

Ten Chinese pharmaceutical companies were recognised at CPHI China for their successful international expansion – Lunan Pharmaceutical Group Corporation and BrightGene Bio-Medical Technology Co., Ltd. are two of them.

We congratulate our long-standing clients on receiving the Leading Enterprises of Pharma Internationalization award – a remarkable success that we were honoured to contribute to as their European consulting partner.

Dr Frank Wienen and Dr Ulrich Korell have been exploring the CPHI exhibition grounds in Shanghai since yesterday morning.

“How’s it going?” the team back at the office asks.

Frank Wienen reports directly from Shanghai: “We are especially impressed by the superb organisation and the international atmosphere: more than 3,500 exhibitors, busy activity at every stand and a lively, professional and open exchange among experts from all over the world. We have already made initial contacts with potential new customers; today our schedule is filled with meetings with existing clients. One thing is clear – PharmaKorell will certainly be back next year.”

Our schedule for this week’s CPHI in China is taking shape.

Among other engagements, Dr Ulrich Korell and Dr Frank Wienen will be attending the following events:

• CPHI Pharmaceutical Innovation and Development Forum 2025
• 2025 CPHI International Regulatory Agencies Updates and Q&A Session
• 10th CPHI Biopharmaceuticals Outlook Summit

While some meetings have already been confirmed, there is still room to explore synergies and engage in interesting conversations. Ulrich and Frank will be in China until Friday, 27 June.

For meeting requests, feel free to send us a private message via LinkedIn or email us at Ulrich.Korell@pharmakorell.com.

Monika Kaur Wagner, Consultant and Head of Quality Assurance/QMR, has now been part of the PharmaKorell team in Lörrach for five months. In a short interview, she shares her impressions of the company culture and talks about the experiences she’s had during her onboarding journey.

How did you experience the transition from Deputy Head of Quality Assurance to Head of Quality Assurance?

In the first three months, I was particularly supported by Lucia Vitellozzi and Matthias Barth. They patiently explained the processes to me, guided me through the systems step by step, and always took the time to answer my many questions with expertise. I am very grateful for their dedication and perseverance.

My line manager, Ulrich Korell, who had temporarily taken over the role of Head of Quality Assurance, consistently supported me with advice and practical help whenever I had questions, and regularly made time for me.

Thanks to close coordination with the team, I was able to familiarise myself quickly and contribute actively to the daily tasks from the outset. I experienced the transition from deputy to head as a smooth and seamless process.

In your introductory post, you quoted Hermann Hesse: “You have to try the impossible to achieve the possible.” Can you share an example where this has applied in your time at PharmaKorell?

Fortunately, during my first few months at PharmaKorell, there hasn’t yet been a situation where I needed to attempt the impossible.

How would you describe the company culture at PharmaKorell compared to your previous workplaces? Are there any aspects you particularly appreciate or found surprising?

What stands out to me most is the openness and how genuinely values are lived here. Both managing directors listen carefully when you share ideas for improvement. They take time for real conversations, encourage dialogue, and make sure everyone is on the same page. That kind of openness really makes you feel heard and taken seriously.

There’s also a very flat hierarchy, and mutual respect is something you can feel in the day-to-day work. People value each other – it’s something you notice. It’s rare to find such a natural balance of professionalism and authentic teamwork.

What advice would you give to new team members starting in a similar role at PharmaKorell?

Stick to the onboarding plan and aim to complete the steps within the given timeframe – it’s taken seriously at PharmaKorell, and for good reason. It gives you structure, helps you find your feet faster, and builds confidence in the processes early on. 

This year, PharmaKorell once again participated in the Swiss Biotech Day. Dr Konrad Dreizler, Dr Frank Wienen and Dr Ulrich Korell represented the company in Basel. As a member of the renowned Swiss Biotech Association, we took the opportunity to attend the general assembly, selected presentations, panel discussions and networking events to identify current industry trends and initiate new partnerships.

In the following brief interview with Konrad, we share some key impressions and highlights from the event.

This was your first time attending the Swiss Biotech Day in Basel. How did the event begin for you?

The Swiss Biotech Day opened with a Welcome Reception at the Markthalle Basel on Sunday evening. The informal setting with standing tables, drinks and snacks provided an ideal environment for networking. There was a strong turnout, and the atmosphere was open and engaging – it was easy to start conversations and make new contacts.

What were your main impressions of the first day, particularly regarding the General Assembly and the technical presentations?

The main exhibition day began on Monday for Ulrich and me. While the exhibition stands were still being set up, we took the opportunity to align internally.

At 10 a.m., we attended the General Assembly of the Swiss Biotech Association. The 2024 Annual Report was presented, key achievements from the past year were reviewed, members voted on strategic matters, new board members were introduced, and a preview of 2025 was shared. Two emerging companies from Basel also presented their projects.

The remainder of the day included numerous short presentations by biotech companies at various stages of development. These sessions were complemented by discussions at the exhibition stands, where attendees had the chance to connect with potential clients and explore collaborative opportunities.

There were also numerous panel discussions. A particular highlight for me was the Swissmedic session, where three companies shared their experiences with the regulatory approval process and identified areas for potential improvement.

How was the second day of the event for you?

On Tuesday, I attended the exhibition with Frank. I initially focused on international delegations and had valuable conversations with participants from Estonia, Taiwan, South Korea and Australia. Later in the day, I joined further presentations and panel discussions that introduced innovative biotech initiatives.

One particular highlight was the presentation by Basilea. The company develops antifungal and antibacterial therapies. The session focused on three pipeline products: Fosmanogepix (antifungal: candidaemia/invasive candidiasis), BAL2062 (antifungal: invasive aspergillosis), and BAL2420 (antibacterial: severe Enterobacteriaceae infections).

I also found the short presentation by BeiGene, titled “Building a New Model for Oncology Innovation”, to be highly compelling. The company’s rapid growth and the increasing number of patients it now serves were particularly noteworthy. In addition, it was announced that the company will be rebranding under the new name BeOne in the future.

Will PharmaKorell participate again next year?

The Swiss Biotech Day is a well-structured and insightful event. We certainly plan to participate again next year.